What is CVE-2023-31923?

CVE-2023-31923 is a high-severity vulnerability in Supremainc Biostar 2, classified under Improper Preservation of Permissions. CVSS score: 8.8/10. Published 2023-05-22.

How severe is CVE-2023-31923?

High severity. CVSS v3 base score is 8.8 out of 10.

Vulnerability in Supremainc Biostar 2

CVE-2023-31923

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

EPSS: 0.009 (56.6th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Supremainc Biostar_2
N/a — versions n/a

Weakness classification (CWE)

CWE-281 — Improper Preservation of Permissions

References

cve@mitre.org (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2023-31923?: CVE-2023-31923 is a high-severity vulnerability in Supremainc Biostar 2, classified under Improper Preservation of Permissions. CVSS score: 8.8/10. Published 2023-05-22.
How severe is CVE-2023-31923?: High severity. CVSS v3 base score is 8.8 out of 10.